Bacteriological and resistance profile in isolates from diabetic patients

North American Journal of Medical Sciences

Volumn 4, Issue 11, 2012, Pages 563-568

  Rawat, Vinita ^a   Singhai, Monil ^a   Kumar, Ashok ^a   Jha, Pawan Kumar ^a   Goyal, Rajeev ^a  

^a Government Medical College   (India)

Author keywords

Antibiotic resistance; Diabetes mellitus; Therapeutic failure

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE AMPC; CEFALEXIN; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; COTRIMOXAZOLE; EDETIC ACID; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LINEZOLID; METALLO BETA LACTAMASE; METICILLIN; MINOCYCLINE; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; TAZOBACTAM; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 84869382625     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.103315     Document Type: Article

References (28)

1. Devraj S, Goyal R, Jialal I. Infammation, oxidative stress and metabolic syndrome, US endocrinology. London: Touch Briefings; 2008. p. 32-37.
2. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-288.
3. Marble A, White HJ, Fernald AT. The nature of the lowered resistance to infection in diabetes mellitus. J Clin Invest 1938;17:423-430.
4. Zubair M, Abida M, Jamal A. Clinicobacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in North India. Biol Med 2010;2:22-34.
5. Luo G, Spellberg B, Gebremariam T, Bolaris M, Lee H, Fu Y, et al. Diabetic murine models for Acinetobacter baumannii infection. J Antimicrob Chemother 2012;67:1439-1445.
6. th ed. New Delhi: Churchill Livingstone; 2006. p. 131-145.
7. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility test. Vol. 1, no. 1, M2 A9. Pennsylvania, USA: Clinical and Laboratory Standard Institute; 2007.
8. Apelqvist J, Bakker K, van Houtum WH, Schaper NC The development of global consensus guidelines on the management of the diabetic foot. Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2008;2 Suppl1:S116-S193.
9. Clinical and Laboratory Standard Institute. Screening and confirmatory test for ESBLs. Vol. 27, no. 1, M2 A9. Pennsylvania, USA: Clinical and laboratory Standard Institute; 2007.
10. Ruppé E, Bidet P, Verdet C, Arlet G, Bingen E. First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J Clin Microbiol 2006;44:4204-4207.
11. Rawat V. Study of mettalo-β-talactamses production in noscomial nil fermenter from gram-negative bacilli in a tertiary care centre. Int J App Basic Med Res 2011;1:139-140.
12. Clinical and Laboratory Standard Institute. Disc diffusion test for prediction of mec A mediated resistance in Staphylococci; sixteenth informational supplement. vol. 27, no. 1, M2 A9. 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898. USA: Clinical and laboratory Standard Institute; 2007.
13. Clinical and Laboratory Standard Institute. MIC interpretive standards (μg/ml) for Staphylococcal spp. vol. 27, no. 1, M2 A9. 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898. USA: Clinical and laboratory Standard Institute; 2007.
14. Clinical and Laboratory Standard Institute Screening test for high level aminoglycoside resistance vol. 27, no. 1, M2 A9. 940 West Valley Road, Suite 1400, Wayne, Pennysylvania 19087-1898.USA. Clinical and Laboratory Standard Institute; 2007.
15. Rawat V. Inducible clindamycin resistance among gram-positive cocci in a tertiary care centre. J Pure Appl Microbiol 2012;6:455-458.
16. Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 2008;51:204-208.
17. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006;29:1727-1732.
18. Motta RN, Oliveira MM, Magalhães PS, Dias AM, Aragão LP, Forti AC, et al. Plasmid-mediated extended-spectrum beta-lactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center. Braz J Infect Dis 2003;7:129-134.
19. Varaiya A, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients. Indian J Pathol Microbiol 2008;51:200-203.
20. Sotto A, Lina G, Richard JL, Combescure C, Bourg G, Vidal L, et al. Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: A new paradigm. Diabetes Care 2008;31:2318-2324.
21. st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-951,
22. Shahid M, Umesh, Sobia F, Singh A, Khan HM, Malik A, et al. Molecular epidemiology of carbapenem resistant Enterobacteriaceae from a North Indian Tertiary Hospital. NZ J Med Lab Sci 2012;66:5-7.
23. Umadevi S, Kumar S, Joseph NM, Easow JM, Kandhakumari G, Srirangaraj S, et al. Microbiological study of diabetic foot infections. Indian J Med Spec 2011;2:12-17.
24. Lee JH, Bae IK, Lee SH. New defnitions of extended-spectrum p-lactamase conferring worldwide emerging antibiotic resistance. Med Res Rev 2012;32:216-232.
25. Shahid M, Singhai M, Malik A, Shukla I, Khan HM, Shujatullah F, et al. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase. J Antimicrob Chemother 2007;60:187-188.
26. Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, Chaudhry R. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Indian J Med Res 2006;123:571-573.
27. Peer MA, Nasir RA, Kakru DK, Fomda BA, Bashir G, Sheikh IA. Sepsis due to linezolid resistant Staphylococcus cohnii and Staphylococcus kloosii: First reports of linezolid resistance in coagulase negative staphylococci from India. Indian J Med Microbiol 2011;29:60-72.
28. Kalawat U, Sharma KK, Reddy S. Linezolid-resistant Staphylococcus spp. at a tertiary care hospital of Andhra Pradesh. Indian J Med Microbiol 2011;29:314-315.